Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-31,100
Closed -$14.1K 2540
2025
Q2
$14.1K Buy
31,100
+5,200
+20% +$2.26K ﹤0.01% 2413
2025
Q1
$10.5K Hold
25,900
﹤0.01% 2281
2024
Q4
$17.1K Hold
25,900
﹤0.01% 2275
2024
Q3
$22K Hold
25,900
﹤0.01% 2694
2024
Q2
$17.3K Buy
25,900
+14,200
+121% +$11.8K ﹤0.01% 2672
2024
Q1
$15.2K Buy
+11,700
New +$12.3K ﹤0.01% 2654
2020
Q3
Sell
-290,907
Closed -$2.57M 2478
2020
Q2
$2.57M Buy
+290,907
New +$836K ﹤0.01% 1237

Other funds holding VXRT

Prudential Financial's VXRT Position: Q3 2025 in Review

Prudential Financial sold out of Vaxart (VXRT) in Q3 2025, closing a stake of 31,100 shares — an estimated $14.1K sold.

Prudential Financial first reported a position in VXRT in Q2 2020 and held it in 7 quarters. The position peaked at $2.57M in Q2 2020. 17 funds tracked by Wall St. Rank hold VXRT as of Q3 2025.

  • Prudential Financial reported no remaining Vaxart position as of Q3 2025 after selling out during the quarter.
  • Prudential Financial sold 31,100 Vaxart shares in Q3 2025, an estimated $14.1K.
  • Prudential Financial first reported a position in Vaxart in Q2 2020 and held it in 7 quarters.
  • Prudential Financial's Vaxart position peaked at $2.57M in Q2 2020.
  • 17 funds tracked by Wall St. Rank held Vaxart as of Q3 2025.

Based on Prudential Financial's 13F filing for Q3 2025, filed 13 Nov 2025.